Artigo de periodico

NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)

• Authors:
  • Pereira, Daniela A.
  • Sandrim, Valeria C.
  • Palei, Ana C.
  • Amaral, Lorena M.
  • Belo, Vanessa A.
  • Lacchini, Riccardo
  • Cavalli, Ricardo de Carvalho
  • Tanus-Santos, José Eduardo
  • Luizon, Marcelo R.
• USP affiliated authors: LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
• Unidades: EERP; FMRP
• DOI: 10.2217/pgs-2021-0006
• Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR); CITOCINAS; ÓXIDO NÍTRICO; POLIMORFISMO; PRÉ-ECLÂMPSIA
• Keywords: Antihypertensive agents; Genetic polymorphisms; Nicotinamide phosphoribosyltransferase; Nitric oxide; Pharmacogenetics; Preeclampsia; SFlt-1; Visfatin/NAMPT
• Agências de fomento:
  • Financiamento CAPES
  • Financiamento CNPq
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2021
• Source:
  • Título: Pharmacogenomics
  • ISSN: 1462-2416
  • Volume/Número/Paginação/Ano: v. 22, n. 8, p. 451-464, 2021


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui versão em acesso aberto em repositório (Green Open Access)

Versão do Documento:

Versão submetida (Pré-print)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	003086088.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 31 mar. 2026.

• APA

  Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006

• NLM

  Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/pgs-2021-0006

• Vancouver

  Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2026 mar. 31 ] Available from: https://doi.org/10.2217/pgs-2021-0006

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
• ENOS tagging SNP haplotypes in hypertensive disorders of pregnancy
• Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
• Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
• Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
• Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy
• Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
• Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
• Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
• Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy